-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOAFFINITY TECHNOLOGIES REPORTS POSITIVE PRECLINICAL FINDINGS SHOWING PROPRIETARY GENE SILENCING TECHNOLOGY IS SELECTIVELY CYTOTOXIC TO SQUAMOUS SKIN CANCER CELLS WITHOUT HARMING HEALTHY CELLS

Reuters·06/22/2026 12:00:02

Please log in to view news